148 related articles for article (PubMed ID: 10675411)
1. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice.
Solorzano A; Zheng H; Fodor E; Brownlee GG; Palese P; García-Sastre A
J Gen Virol; 2000 Mar; 81(Pt 3):737-42. PubMed ID: 10675411
[TBL] [Abstract][Full Text] [Related]
2. Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model.
Mishin VP; Nedyalkova MS; Hayden FG; Gubareva LV
Vaccine; 2005 Apr; 23(22):2922-7. PubMed ID: 15780741
[TBL] [Abstract][Full Text] [Related]
3. Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.
Hui EK; Smee DF; Wong MH; Nayak DP
J Virol; 2006 Jun; 80(12):5697-707. PubMed ID: 16731908
[TBL] [Abstract][Full Text] [Related]
4. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.
Kash JC; Basler CF; García-Sastre A; Carter V; Billharz R; Swayne DE; Przygodzki RM; Taubenberger JK; Katze MG; Tumpey TM
J Virol; 2004 Sep; 78(17):9499-511. PubMed ID: 15308742
[TBL] [Abstract][Full Text] [Related]
5. Introduction of silent mutations into the NP gene of influenza A viruses as a possible strategy for the creation of a live attenuated vaccine.
Anhlan D; Hrincius ER; Scholtissek C; Ludwig S
Vaccine; 2012 Jun; 30(30):4480-9. PubMed ID: 22575164
[TBL] [Abstract][Full Text] [Related]
6. Live bivalent vaccine for parainfluenza and influenza virus infections.
Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
[TBL] [Abstract][Full Text] [Related]
7. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
8. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
[TBL] [Abstract][Full Text] [Related]
9. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets.
Zhong G; Fan S; Hatta M; Nakatsu S; Walters KB; Lopes TJS; Wang JI; Ozawa M; Karasin A; Li Y; Tong S; Donis RO; Neumann G; Kawaoka Y
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801857
[TBL] [Abstract][Full Text] [Related]
11. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
[TBL] [Abstract][Full Text] [Related]
12. Sequential addition of temperature-sensitive missense mutations into the PB2 gene of influenza A transfectant viruses can effect an increase in temperature sensitivity and attenuation and permits the rational design of a genetically engineered live influenza A virus vaccine.
Subbarao EK; Park EJ; Lawson CM; Chen AY; Murphy BR
J Virol; 1995 Oct; 69(10):5969-77. PubMed ID: 7666501
[TBL] [Abstract][Full Text] [Related]
13. Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.
Liu T; Ye Z
J Virol; 2005 Feb; 79(3):1918-23. PubMed ID: 15650216
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of an influenza A virus due to alteration of its hemagglutinin-neuraminidase functional balance in mice.
Gen F; Yamada S; Kato K; Akashi H; Kawaoka Y; Horimoto T
Arch Virol; 2013 May; 158(5):1003-11. PubMed ID: 23247916
[TBL] [Abstract][Full Text] [Related]
15. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
[TBL] [Abstract][Full Text] [Related]
16. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
17. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
[TBL] [Abstract][Full Text] [Related]
18. Introduction of foreign sequences into the genome of influenza A virus.
García-Sastre A; Percy N; Barclay W; Palese P
Dev Biol Stand; 1994; 82():237-46. PubMed ID: 7525392
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.
Shinya K; Fujii Y; Ito H; Ito T; Kawaoka Y
J Virol; 2004 Mar; 78(6):3083-8. PubMed ID: 14990727
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of attenuation of a chimeric influenza A/B transfectant virus.
Luo G; Bergmann M; Garcia-Sastre A; Palese P
J Virol; 1992 Aug; 66(8):4679-85. PubMed ID: 1629948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
